Pharmaview Inc (DOB: Far Hills Pharmacy)

Form 483 issued November 13, 2019 · Bedminster, New Jersey

Inspection
Nov 1 – Nov 13, 2019
Observations
2
Pages
2
FEI number
3005824513

In short: On November 13, 2019, FDA issued a Form 483 with 2 observations to Pharmaview Inc (DOB: Far Hills Pharmacy) in Bedminster, New Jersey (FEI 3005824513) after an inspection that ran Nov 1 – Nov 13, 2019. The investigators were Emmanuel J. Ramos Maldonado and Rose Jean-Mary. Most observations concern facilities & equipment and materials.

At a glance

Facilities & equipment and materials account for 2 of 2 observations.

Facilities & equipment1
Materials1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Hazardous drugs were compounded without providing adequate containment or cleaning of multi-use…

  2. 02

    Non-Pharmaceutical grade components are use in the formulation…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Pharmaview Inc (DOB: Far Hills Pharmacy)?

FDA listed 2 observations on this Form 483, mostly about facilities & equipment and materials. The opening words of each observation are shown on this page.

Who inspected Pharmaview Inc (DOB: Far Hills Pharmacy)?

Emmanuel J. Ramos Maldonado and Rose Jean-Mary are named on this Form 483, for the inspection of Nov 1 – Nov 13, 2019. Each investigator has a profile showing what they cite most.

When was Pharmaview Inc (DOB: Far Hills Pharmacy) inspected by FDA?

The inspection ran Nov 1 – Nov 13, 2019, and the Form 483 is dated November 13, 2019.

How do I get the full Form 483 for Pharmaview Inc (DOB: Far Hills Pharmacy)?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free